Use access key #2 to skip to page content.
$39.58 3.08 (8.44%)
10/13/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar gt95ab (58.67) Submitted: 4/02/08 5:01 PM : Outperform Start Price: $40.52 AZN Score: 31.55

One man's hell, is another man's jacuzzi...





Vytorin ENHANCE study will only help Crestor sales, giving AstraZeneca good growth that will definitely outperform.

Report this Post Replies: 0 | Reply

Featured Broker Partners